Towards prediction and therapeutic targets of Alzheimer's disease through directed analysis of genetic risk loci. University of Antwerp
Alzheimer's disease (AD) is the predominant form of dementia and one of the principal challenges in modern medicine. In 2015, an estimated 46.8 million people suffer from dementia with a global cost of US$ 818 billion. Due to our worldwide aging society, the number of patients is projected to double every 20 years, posing a tremendous burden on patients, society and economy. Finding a cure is paramount to avoid this calamity, but AD clinical ...